181 related articles for article (PubMed ID: 38688579)
1. ScRNA-seq reveals novel immune-suppressive T cells and investigates CMV-TCR-T cells cytotoxicity against GBM.
Long X; Zhang Z; Li Y; Deng K; Gao W; Huang M; Wang X; Lin X; She X; Zhao Y; Zhang M; Huang C; Wang S; Du Y; Du P; Chen S; Liu Q; Wu M
J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38688579
[TBL] [Abstract][Full Text] [Related]
2. CMV-independent lysis of glioblastoma by ex vivo expanded/activated Vδ1+ γδ T cells.
Knight A; Arnouk H; Britt W; Gillespie GY; Cloud GA; Harkins L; Su Y; Lowdell MW; Lamb LS
PLoS One; 2013; 8(8):e68729. PubMed ID: 23950874
[TBL] [Abstract][Full Text] [Related]
3. The detection of CMV pp65 and IE1 in glioblastoma multiforme.
Lucas KG; Bao L; Bruggeman R; Dunham K; Specht C
J Neurooncol; 2011 Jun; 103(2):231-8. PubMed ID: 20820869
[TBL] [Abstract][Full Text] [Related]
4. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus-Mediated T Cell Receptor Repertoire Perturbation Is Present in Early Life.
Attaf M; Roider J; Malik A; Rius Rafael C; Dolton G; Predergast AJ; Leslie A; Ndung'u T; Kløverpris HN; Sewell AK; Goulder PJ
Front Immunol; 2020; 11():1587. PubMed ID: 33101265
[TBL] [Abstract][Full Text] [Related]
6. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Ghazi A; Ashoori A; Hanley PJ; Brawley VS; Shaffer DR; Kew Y; Powell SZ; Grossman R; Grada Z; Scheurer ME; Hegde M; Leen AM; Bollard CM; Rooney CM; Heslop HE; Gottschalk S; Ahmed N
J Immunother; 2012; 35(2):159-68. PubMed ID: 22306904
[TBL] [Abstract][Full Text] [Related]
7. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
[TBL] [Abstract][Full Text] [Related]
8. Dissecting the Landscape of Activated CMV-Stimulated CD4+ T Cells in Humans by Linking Single-Cell RNA-Seq With T-Cell Receptor Sequencing.
Lyu M; Wang S; Gao K; Wang L; Zhu X; Liu Y; Wang M; Liu X; Li B; Tian L
Front Immunol; 2021; 12():779961. PubMed ID: 34950144
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme.
Crough T; Beagley L; Smith C; Jones L; Walker DG; Khanna R
Immunol Cell Biol; 2012 Oct; 90(9):872-80. PubMed ID: 22508289
[TBL] [Abstract][Full Text] [Related]
10. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Dziurzynski K; Wei J; Qiao W; Hatiboglu MA; Kong LY; Wu A; Wang Y; Cahill D; Levine N; Prabhu S; Rao G; Sawaya R; Heimberger AB
Clin Cancer Res; 2011 Jul; 17(14):4642-9. PubMed ID: 21490182
[TBL] [Abstract][Full Text] [Related]
11. TCR repertoire evolution during maintenance of CMV-specific T-cell populations.
Schober K; Buchholz VR; Busch DH
Immunol Rev; 2018 May; 283(1):113-128. PubMed ID: 29664573
[TBL] [Abstract][Full Text] [Related]
12. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Atlas Reveals Complexity of the Immunosuppressive Microenvironment of Initial and Recurrent Glioblastoma.
Fu W; Wang W; Li H; Jiao Y; Huo R; Yan Z; Wang J; Wang S; Wang J; Chen D; Cao Y; Zhao J
Front Immunol; 2020; 11():835. PubMed ID: 32457755
[TBL] [Abstract][Full Text] [Related]
14. A new clustering method identifies multiple sclerosis-specific T-cell receptors.
Hayashi F; Isobe N; Glanville J; Matsushita T; Maimaitijiang G; Fukumoto S; Watanabe M; Masaki K; Kira JI
Ann Clin Transl Neurol; 2021 Jan; 8(1):163-176. PubMed ID: 33400858
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Adaptive-like γδ T Cells in Ugandan Infants during Primary Cytomegalovirus Infection.
Tuengel J; Ranchal S; Maslova A; Aulakh G; Papadopoulou M; Drissler S; Cai B; Mohsenzadeh-Green C; Soudeyns H; Mostafavi S; van den Elzen P; Vermijlen D; Cook L; Gantt S
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696417
[TBL] [Abstract][Full Text] [Related]
16. The N
Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
Front Immunol; 2021; 12():653711. PubMed ID: 34354698
[TBL] [Abstract][Full Text] [Related]
17. Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
Lamano JB; Quaggin-Smith JA; Horbinski CM; Tate MC; Grimm SA; Kumthekar PU; Bloch O
J Clin Neurosci; 2019 Jun; 64():18-21. PubMed ID: 30948314
[TBL] [Abstract][Full Text] [Related]
18. Major TCR Repertoire Perturbation by Immunodominant HLA-B
Attaf M; Malik A; Severinsen MC; Roider J; Ogongo P; Buus S; Ndung'u T; Leslie A; Kløverpris HN; Matthews PC; Sewell AK; Goulder P
Front Immunol; 2018; 9():2539. PubMed ID: 30487790
[TBL] [Abstract][Full Text] [Related]
19. Enhancing Glioblastoma Immunotherapy with Integrated Chimeric Antigen Receptor T Cells through the Re-Education of Tumor-Associated Microglia and Macrophages.
Zhu N; Chen S; Jin Y; Wang M; Fang L; Xue L; Hua D; Zhang Z; Jia M; Hao M; Zhang C
ACS Nano; 2024 Apr; 18(17):11165-11182. PubMed ID: 38626338
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Weathers SP; Penas-Prado M; Pei BL; Ling X; Kassab C; Banerjee P; Bdiwi M; Shaim H; Alsuliman A; Shanley M; de Groot JF; O'Brien BJ; Harrison R; Majd N; Kamiya-Matsuoka C; Fuller GN; Huse JT; Chi L; Rao G; Weinberg JS; Lang FF; Sawaya R; Shpall EJ; Rezvani K; Heimberger AB
Clin Cancer Res; 2020 Jul; 26(14):3565-3577. PubMed ID: 32299815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]